These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 6171520)

  • 1. High-molecular-weight polysaccharide antigen from Pseudomonas aeruginosa immunotype 2.
    Pier GB; Sidberry HF; Sadoff JC
    Infect Immun; 1981 Nov; 34(2):461-8. PubMed ID: 6171520
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunochemistry of Pseudomonas aeruginosa lipopolysaccharides and high-molecular-weight polysaccharides.
    Pier GB
    Rev Infect Dis; 1983; 5 Suppl 5():S950-6. PubMed ID: 6197738
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural analysis and immunogenicity of Pseudomonas aeruginosa immunotype 2 high molecular weight polysaccharide.
    Pier GB; Bennett SE
    J Clin Invest; 1986 Feb; 77(2):491-5. PubMed ID: 3080477
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isolation and characterization of a high-molecular-weight polysaccharide from the slime of Pseudomonas aeruginosa.
    Pier GB; Sidberry HF; Zolyomi S; Sadoff JC
    Infect Immun; 1978 Dec; 22(3):908-18. PubMed ID: 103840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunochemical characterization of high-molecular-weight polysaccharide from Fisher immunotype 3 Pseudomonas aeruginosa.
    Pier GB; Pollack M; Cohen M
    Infect Immun; 1984 Aug; 45(2):309-13. PubMed ID: 6430805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protective immunity induced in mice by immunization with high-molecular-weight polysaccharide from Pseudomonas aeruginosa.
    Pier GB; Sidberry HF; Sadoff JC
    Infect Immun; 1978 Dec; 22(3):919-25. PubMed ID: 103841
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pseudomonas aeruginosa immunotype 5 polysaccharide-toxin A conjugate vaccine.
    Cryz SJ; Furer E; Sadoff JC; Germanier R
    Infect Immun; 1986 Apr; 52(1):161-5. PubMed ID: 3082756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. O-polysaccharide-protein conjugates induce high levels of specific antibodies to Pseudomonas aeruginosa immunotype 3 lipopolysaccharide.
    van de Wiel PA; Witvliet MH; Evenberg D; Derks HJ; Beuvery EC
    Vaccine; 1987 Mar; 5(1):33-8. PubMed ID: 2437718
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cross-protection by Pseudomonas aeruginosa polysaccharides.
    Pier GB
    Infect Immun; 1982 Dec; 38(3):1117-22. PubMed ID: 6185423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure of an extracellular cross-reactive polysaccharide from Pseudomonas aeruginosa immunotype 4.
    Kocharova NA; Knirel YA; Shashkov AS; Kochetkov NK; Pier GB
    J Biol Chem; 1988 Aug; 263(23):11291-5. PubMed ID: 3136157
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biologic activities of antibodies to the neutral-polysaccharide component of the Pseudomonas aeruginosa lipopolysaccharide are blocked by O side chains and mucoid exopolysaccharide (alginate).
    Hatano K; Goldberg JB; Pier GB
    Infect Immun; 1995 Jan; 63(1):21-6. PubMed ID: 7528730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isolation, structure, and immunogenicity of Pseudomonas aeruginosa immunotype 4 high-molecular-weight polysaccharide.
    Pier GB; Pollack M
    Infect Immun; 1989 Feb; 57(2):426-31. PubMed ID: 2492260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preparation and characterization of a nontoxic polysaccharide-protein conjugate that induces active immunity and passively protective antibody against Pseudomonas aeruginosa immunotype 1 in mice.
    Tsay GC; Collins MS
    Infect Immun; 1984 Jul; 45(1):217-21. PubMed ID: 6429046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Further purification and characterization of high-molecular-weight polysaccharide from Pseudomonas aeruginosa.
    Pier GB; Cohen M; Jennings H
    Infect Immun; 1983 Dec; 42(3):936-41. PubMed ID: 6417026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunization with Pseudomonas aeruginosa high-molecular-weight polysaccharides prevents death from Pseudomonas burn infections in mice.
    Pollack M; Pier GB; Prescott RK
    Infect Immun; 1984 Feb; 43(2):759-60. PubMed ID: 6420347
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunologic basis for mouse protection provided by high-molecular-weight polysaccharide from immunotype 1 Pseudomonas aeruginosa.
    Markham RB; Pier GB
    Rev Infect Dis; 1983; 5 Suppl 5():S957-62. PubMed ID: 6419317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction in mice of cell-mediated immunity to Pseudomonas aeruginosa by high molecular weight polysaccharide and vinblastine.
    Pier GB; Markham RB
    J Immunol; 1982 May; 128(5):2121-5. PubMed ID: 6174622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protection against fatal Pseudomonas aeruginosa sepsis by immunization with smooth and rough lipopolysaccharides.
    Cryz SJ; Meadow PM; Fürer E; Germanier R
    Eur J Clin Microbiol; 1985 Apr; 4(2):180-5. PubMed ID: 3924605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polysaccharide antigens of Pseudomonas aeruginosa.
    Pier GB
    Rev Infect Dis; 1988; 10 Suppl 2():S337-40. PubMed ID: 3142017
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunogenic and antigenic properties of a heptavalent high-molecular-weight O-polysaccharide vaccine derived from Pseudomonas aeruginosa.
    Hatano K; Boisot S; DesJardins D; Wright DC; Brisker J; Pier GB
    Infect Immun; 1994 Sep; 62(9):3608-16. PubMed ID: 7520416
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.